Robert Stefanovich - 09 Mar 2024 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Financial Officer
Signature
/s/ Robert Stefanovich
Issuer symbol
CYRX
Transactions as of
09 Mar 2024
Net transactions value
-$34,271
Form type
4
Filing time
19 Mar 2024, 19:51:12 UTC
Previous filing
30 Aug 2023
Next filing
26 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $0 +2,666 +2.2% $0.000000 125,816 09 Mar 2024 Direct F1
transaction CYRX Common Stock Sale $18,298 -1,119 -0.89% $16.35 124,697 11 Mar 2024 Direct F2
transaction CYRX Common Stock Sale $15,972 -1,035 -0.83% $15.43 123,662 15 Mar 2024 Direct F2
transaction CYRX Common Stock Award $0 +5,750 +4.6% $0.000000 129,412 15 Mar 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Restricted Stock Rights Options Exercise $0 -2,666 -50% $0.000000 2,667 09 Mar 2024 Common Stock 2,666 Direct F1, F4
transaction CYRX Stock Option (right to buy) Award $0 +11,500 $0.000000 11,500 15 Mar 2024 Common Stock 11,500 $16.70 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
F2 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F3 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
F4 The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
F5 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.